A similar share of large employers covering GLP-1 agonists for weight loss say that use was higher than expected in California, as it was nationally (31% and 24%)
When ipamorelin binds this receptor, it triggers a Gq-protein cascade that depolarizes the somatotroph and releases GH from secretory granules
Transitioning from weight loss to maintenance Determining goal weight achievement: Lost 10-12% body weight (cagrilintide alone) Lost 15-25% body weight (CagriSema) Weight stable for 4-8 weeks Satisfied with current weight Ready to focus on maintenance Maintenance dose options comparison: Option 1: Continue same dose Keep cagrilintide at 2.4mg weekly Ensures no regain Most conservative approach Highest cost Option 2: Reduce dose slightly Decrease to 1.8-2.0mg weekly Monitor weight for 4 weeks If stable, maintain If gaining, increase back 20-25% cost savings Option 3: Try every 10 days Instead of weekly, inject every 10 days Effectively 30% dose reduction Some maintain weight this way Requires close monitoring Recommendation: Try Option 2 first (reduce to 1.8-2.0mg)
Each escalation raised the stakes
Access Affordable Treatment Through a Compounding Pharmacy for GLP-1 Medications in Maryland GLP-1 medications have changed weight loss treatment but are often expensive, with popular brands like Ozempic, Wegovy, and Mounjaro costing over $1,000 per month without insurance